Melatonin and Hycodan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Melatonin (melatonin) and Hycodan (homatropine methylbromide; hydrocodone bitartrate). Common drug interactions include fatigue among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Melatonin and Hycodan. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Melatonin?

Melatonin has active ingredients of melatonin. It is often used in insomnia. eHealthMe is studying from 56,212 Melatonin users. Check the latest studies of Melatonin.

What is Hycodan?

Hycodan has active ingredients of homatropine methylbromide; hydrocodone bitartrate. It is often used in cough. eHealthMe is studying from 769 Hycodan users. Check the latest studies of Hycodan.



On Jul, 07, 2026

22 people who take Melatonin and Hycodan together, and have interactions are studied.

Melatonin and Hycodan drug interactions.

What are the common drug interactions of Melatonin and Hycodan, by gender? *:

female:

  1. Fatigue (feeling of tiredness)
  2. Infusion related reaction
  3. Asthma
  4. Diarrhoea
  5. Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs)
  6. Mycobacterium avium complex infection
  7. Nasopharyngitis (inflammation of the nasopharynx)
  8. Nausea (feeling of having an urge to vomit)
  9. Osteoporosis (bones weak and more likely to break)
  10. Pneumonia

male:

  1. Pneumonia
  2. Blood pressure increased
  3. Atelectasis (partial or complete collapse of the lung)
  4. Back pain
  5. Balance disorder
  6. Benign neoplasm of skin (benign (non-cancerous) tumours of the skin)
  7. Chest pain
  8. Cytomegalovirus colitis (an inflammation of the colon from virus)
  9. Decreased appetite
  10. Decubitus ulcer (a chronic ulcer of the skin caused by prolonged pressure on it)

What are the common drug interactions of Melatonin and Hycodan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Arthralgia (joint pain)
  2. Csf neutrophil count increased
  3. Csf white blood cell count increased
  4. Dizziness
  5. Drug effect decreased
  6. Fatigue (feeling of tiredness)
  7. Headache (pain in head)
  8. Hemiparesis (weakness on one side of the body)
  9. Hypoaesthesia (reduced sense of touch or sensation)
  10. Nausea (feeling of having an urge to vomit)

40-49:

n/a

50-59:

  1. Dyspnoea (difficult or laboured respiration)
  2. Blood pressure increased
  3. Chest discomfort
  4. Chest pain
  5. Increased appetite
  6. Leukopenia (less number of white blood cells in blood)
  7. Oedema peripheral (superficial swelling)
  8. Transplant rejection (a transplant material is not worked)

60+:

  1. Asthenia (weakness)
  2. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  3. Malaise (a feeling of general discomfort or uneasiness)
  4. Respiratory failure (inadequate gas exchange by the respiratory system)
  5. Uveitis (inflammation of the uvea)
  6. Guillain-barre syndrome (the body's immune system attacks its peripheral nervous system)
  7. Therapeutic response unexpected
  8. Weight increased
  9. Acute respiratory failure
  10. Atelectasis (partial or complete collapse of the lung)

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 5 people, 22.73%
  2. Constipation: 4 people, 18.18%
  3. Nausea (feeling of having an urge to vomit): 4 people, 18.18%
  4. High Blood Pressure: 3 people, 13.64%
  5. Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 3 people, 13.64%
  6. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 3 people, 13.64%
  7. Depression: 3 people, 13.64%
  8. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 13.64%
  9. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 3 people, 13.64%
  10. Pain: 3 people, 13.64%

* Approximation only. Some reports may have incomplete information.

Do you take Melatonin and Hycodan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Melatonin and Hycodan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Melatonin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Hycodan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Melatonin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Hycodan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on melatonin and homatropine methylbromide; hydrocodone bitartrate (the active ingredients of Melatonin and Hycodan, respectively), and Melatonin and Hycodan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: